Absence and rescue of morphine withdrawal in GIRK/Kir3 knock-out mice

J Neurosci. 2008 Apr 9;28(15):4069-77. doi: 10.1523/JNEUROSCI.0267-08.2008.

Abstract

Although morphine induces both analgesia and dependence through mu-opioid receptors (MORs), the respective contributions of the intracellular effectors engaged by MORs remain unknown. To examine the contribution of G-protein-gated inwardly rectifying K(+) (GIRK, Kir3) channels to morphine dependence and analgesia, we quantified naloxone-precipitated withdrawal behavior and morphine analgesia using GIRK knock-out ((-/-)) mice. The morphine withdrawal syndrome was strongly attenuated, whereas morphine analgesia was mostly preserved in mice lacking both GIRK2 and GIRK3 (GIRK2/3(-/-) mice). In acute slices containing the locus ceruleus (LC) from GIRK2/3(-/-) mice, the increase in spontaneous firing typically associated with morphine withdrawal was absent. Moreover, although morphine elicited normal presynaptic inhibition in the LC, postsynaptic GIRK currents were completely abolished in GIRK2/3(-/-) mice. Altogether, these data suggested that morphine-evoked postsynaptic inhibition of the LC was required for the induction of dependence. Consistent with this hypothesis, morphine withdrawal behavior was rescued in GIRK2/3(-/-) mice by ablation of adrenergic fibers using the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine. Our data suggest that inhibition of adrenergic tone is required for the induction of dependence, and that channels containing GIRK2 and GIRK3 serve as an inhibitory gate.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Fibers* / drug effects
  • Analgesia
  • Analgesics, Opioid / adverse effects*
  • Animals
  • Benzylamines / pharmacology
  • Electrophysiology
  • G Protein-Coupled Inwardly-Rectifying Potassium Channels / deficiency*
  • In Vitro Techniques
  • Locus Coeruleus / metabolism
  • Locus Coeruleus / physiopathology
  • Mice
  • Mice, Knockout
  • Morphine / adverse effects*
  • Naloxone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Neural Inhibition*
  • Neurotoxins / pharmacology
  • Substance Withdrawal Syndrome / metabolism
  • Substance Withdrawal Syndrome / physiopathology*
  • Substance-Related Disorders / metabolism
  • Substance-Related Disorders / physiopathology

Substances

  • Analgesics, Opioid
  • Benzylamines
  • G Protein-Coupled Inwardly-Rectifying Potassium Channels
  • Kcnj6 protein, mouse
  • Narcotic Antagonists
  • Neurotoxins
  • Naloxone
  • Morphine
  • DSP 4